You, Y., Xu, Z., & Chen, Y. (2018). Doxorubicin conjugated with a trastuzumab epitope and an MMP-2 sensitive peptide linker for the treatment of HER2-positive breast cancer. Drug Deliv.
Citación estilo ChicagoYou, Yiwen, Zhiyuan Xu, y Yun Chen. "Doxorubicin Conjugated With a Trastuzumab Epitope and an MMP-2 Sensitive Peptide Linker for the Treatment of HER2-positive Breast Cancer." Drug Deliv 2018.
Cita MLAYou, Yiwen, Zhiyuan Xu, y Yun Chen. "Doxorubicin Conjugated With a Trastuzumab Epitope and an MMP-2 Sensitive Peptide Linker for the Treatment of HER2-positive Breast Cancer." Drug Deliv 2018.
Precaución: Estas citas no son 100% exactas.